Security key
53566P109
Lineage Cell Therapeutics, Inc. - Common shares (LCTX)
CUSIP: 53566P109
Q3 2019 13F Holders as of 30 Sep 2019
- Security type / class
- Equity / Common shares
- Shares outstanding
- 250,425,788
- Total 13F shares
- 64,455,811
- Share change
- +64,336,176
- Total reported value
- $63,153,426
- Put/Call ratio
- 67%
- Reported price per share
- $0.98
- Number of holders
- 81
- Value change
- +$63,033,394
- Number of buys
- 80
- Number of sells
- 1
Security identity
Holder snapshot
Report period
Q3 2019
Institutions
81
Top holders
10
LCTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2019
Previous quarter: Q2 2019
Lineage Cell Therapeutics, Inc. SEC filings
Lineage Cell Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 53566P109
Recent filing periods:
Ownership snapshot
Top reported holders of LCTX - Lineage Cell Therapeutics, Inc. - Common shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
SEGALL BRYANT & HAMILL, LLC
13D/G signal
—
Evidence rows
1
Latest as of
30 Jun 2019
13F
Lead comparable stake: 0.01%
Rank 1 holder
SEGALL BRYANT & HAMILL, LLC
13F
- Ownership
- 0.01%
- Position
- $20K
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SEGALL BRYANT & HAMILL, LLC |
13F
Company
|
0.01%
|
$20,000
17,974 shares
|
— | 30 Jun 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
81
Shares
64,455,811
Rows available
81
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
1
Q3 2019 holders
81
Holder diff
80
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 value | Q3 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend